Frontlight ResearchEarly access
Trial site
Jerusalem
- 5running trials
- 7closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Asthma4 trials
- COPD4 trials
- Atopic dermatitis (eczema)3 trials
- Bronchiectasis1 trial
- Cystic fibrosis1 trial
- Phase
- Phase 36 trials
- Phase 24 trials
- Phase 2/31 trial
- Status
- Completed7 trials
- Active, not recruiting3 trials
- Enrolling by invitation1 trial
- Recruiting1 trial
- Lead sponsor
- Sanofi12 trials
Running trials
Recruiting
Active, not recruiting
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026